Strides Pharma Science consolidated net profit rises 77.07% in the December 2024 quarter
Sales rise 14.71% to Rs 1153.67 crore
Net profit of Strides Pharma Science rose 77.07% to Rs 87.95 crore in the quarter ended December 2024 as against Rs 49.67 crore during the previous quarter ended December 2023. Sales rose 14.71% to Rs 1153.67 crore in the quarter ended December 2024 as against Rs 1005.77 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var.Sales1153.671005.77 15 OPM %18.2312.87 -PBDT164.7068.49 140 PBT116.2819.04 511 NP87.9549.67 77Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content